First Time Loading...

Editas Medicine Inc
NASDAQ:EDIT

Watchlist Manager
Editas Medicine Inc Logo
Editas Medicine Inc
NASDAQ:EDIT
Watchlist
Price: 6.12 USD 7.75%
Updated: May 15, 2024

Editas Medicine Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Editas Medicine Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Editas Medicine Inc
NASDAQ:EDIT
Other Liabilities
$79.5m
CAGR 3-Years
0%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.3B
CAGR 3-Years
5%
CAGR 5-Years
17%
CAGR 10-Years
25%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$25.8B
CAGR 3-Years
59%
CAGR 5-Years
29%
CAGR 10-Years
52%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
24%
CAGR 5-Years
62%
CAGR 10-Years
32%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is Editas Medicine Inc's Other Liabilities?
Other Liabilities
79.5m USD

Based on the financial report for Mar 31, 2024, Editas Medicine Inc's Other Liabilities amounts to 79.5m USD.

What is Editas Medicine Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-8%

Over the last year, the Other Liabilities growth was -11%.